Board Meeting
The next board meeting for Nemaura Medical Inc is on 16 Sep 2025 for the purpose of Nemaura Medical Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Nemaura Medical Inc

The latest disclosure was made by Ghadar Arash in Nemaura Medical Inc where a trade of 100,000 Common Stock done at an average price of $0.1 was reported to US exchanges on Jan. 5, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ghadar Arash Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.14 per share. 05 Jan 2024 100,000 100,000 (0%) 0% 0.1 14,000 Common Stock
Justin Mclarney Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 22,293 22,293 (0%) 0% 0 Common Stock
Bashir Timol Director, Chief Business Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 8,000 8,000 - - Stock Option (right to buy)
Timothy Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 8,000 8,000 - - Stock Option (right to buy)
Salim Natha Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 8,000 8,000 - - Stock Option (right to buy)
Dewan Fazlul Hoque Chowdhury Director, CEO & President, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 8,000 8,000 - - Stock Option (right to buy)
Thomas Moore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 8,000 8,000 - - Stock Option (right to buy)
Dewan Fazlul Hoque Chowdhury Director, Chief Executive Officer, Ten Percent Owner 05 Jun 2018 88 0 - - Series A Convertible Preferred Stock
Dewan Fazlul Hoque Chowdhury Director, Chief Executive Officer, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 05 Jun 2018 87,537,000 87,537,000 (42%) 42% 0 Common Stock
Bashir Timol Director, Chief Business Officer 05 Jun 2018 27,082 0 - - Series A Convertible Preferred Stock
Bashir Timol Director, Chief Business Officer Other type of transaction at price $ 0.00 per share. 05 Jun 2018 27,082,000 27,082,100 (13%) 13% 0 Common Stock
Dewan Fazlul Hoque Chowdhury Director, Chief Executive Officer, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 06 Nov 2017 87,537,000 0 - - Common Stock
Bashir Timol Director, Chief Business Officer Other type of transaction at price $ 0.00 per share. 06 Nov 2017 27,082 27,082 - - Series A Convertible Preferred Stock
Bashir Timol Director, Chief Business Officer Other type of transaction at price $ 0.00 per share. 06 Nov 2017 27,082,000 100 - - Common Stock
Dewan Fazlul Hoque Chowdhury Director, Chief Executive Officer, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 06 Nov 2017 87,537 87,537 - - Series A Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures